Combining BET inhibitors and PARP inhibitors might help patients resistant to chemotherapy, the study suggests.

Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

Bristol Myers (BMY)’ treatment of small cell lung cancer, atigotatug plus nivolumab fixed dose combination, received FDA orphan designation, ...

The incidence of brain metastasis is high in patients with non-small-cell lung cancer. Available standard therapeutic options, such as whole-brain radiation therapy and systemic chemotherapy ...

Dr. Gandara has served on the Board of Directors or held other leadership positions with Response Genetics, Inc.; has received research funding from Abbott Laboratories, Bristol-Myers Squibb ...

Purpose: To evaluate the dosimetric parameters and clinical outcomes of hypofractionated stereotactic ... small BMs with a 3-mm PTV margin who were unsuitable for or refused surgical resection and SRS ...

of patients with early-stage non-small cell lung cancer (NSCLC). Specifically, it compared outcomes between sublobar resection, lobectomy, and stereotactic body radiation therapy (SBRT). Methods: A ...

This may affect a small or large area of the lung. Research from 2018 notes that atelectasis may be the first sign of lung cancer. Researchers also state that atelectasis is present in 30 to ⁠35 ...

Dr. Bryant Lin, who teaches medicine at Stanford University, was given a terminal diagnosis. He wanted his students to understand the humanity at the core of medicine. By Kate Selig Photographs by ...

The company's pipeline has evolved significantly in recent years to keep up with demand, with newer cancer therapies making up a rising proportion of its plans for its roster of medicines.

Patients with HCC can experience either early recurrence (true tumor relapse), arising from pre-existing tumor dissemination within 2 years after treatment, or late recurrence (de novo cancer), which ...

A recent study has shown that analysis of ctDNA methylation can aid the early diagnosis of non-small cell lung cancer (NSCLC). This study, published in the Genes and Diseases journal by ...